Literature DB >> 32132133

Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates β-Arrestin Recruitment and Signaling to ERK1/2.

Ilya S Senatorov1, Ameneh Cheshmehkani1, Rebecca N Burns1, Kirti Singh1, Nader H Moniri2.   

Abstract

Free-fatty acid receptor-4 (FFA4), previously termed GPR120, is a G protein-coupled receptor (GPCR) for medium and long-chained fatty acids, agonism of which can regulate a myriad of metabolic, sensory, inflammatory, and proliferatory signals. Two alternative splice isoforms of FFA4 exist that differ by the presence of an additional 16 amino acids in the longer (FFA4-L) transcript, which has been suggested to be an intrinsically β-arrestin-biased GPCR. Although the shorter isoform (FFA4-S) has been studied more extensively, very little is known about mechanisms of regulation or signaling of the longer isoform. Because β-arrestin recruitment is dependent on receptor phosphorylation, in the current study, we used the endogenous agonist docosahexaenoic acid (DHA) to examine the mechanisms of FFA4-L phosphorylation, as well as DHA-dependent β-arrestin recruitment and DHA-dependent extracellular-signal regulated kinase-1/2 (ERK1/2) signaling in human embryonic kidney 293 cells. Our results reveal differences in basal phosphorylation of the two FFA4 isoforms, and we show that DHA-mediated phosphorylation of FFA4-L is primarily regulated by G protein-coupled receptor kinase 6, whereas protein kinase-C can also contribute to agonist-induced and heterologous phosphorylation. Moreover, our data demonstrate that FFA4-L phosphorylation occurs on the distal C terminus and is directly responsible for recruitment and interactions with β-arrestin-2. Finally, using CRISPR/Cas9 genome-edited cells, our data reveal that unlike FFA4-S, the longer isoform is unable to facilitate phosphorylation of ERK1/2 in cells that are devoid of β-arrestin-1/2. Together, these results are the first to demonstrate phosphoregulation of FFA4-L as well as the effects of loss of phosphorylation sites on β-arrestin recruitment and ERK1/2 activation. SIGNIFICANCE STATEMENT: Free-fatty acid receptor-4 (FFA4) is a cell-surface G protein-coupled receptor for medium and long-chained fatty acids that can be expressed as distinct short (FFA4-S) or long (FFA4-L) isoforms. Although much is known about FFA4-S, the longer isoform remains virtually unstudied. Here, we reveal the mechanisms of docosahexaenoic acid-induced phosphorylation of FFA4-L and subsequent β-arrestin-2 recruitment and extracellular-signal regulated kinase-1/2 activity.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32132133      PMCID: PMC7081053          DOI: 10.1124/mol.119.117697

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  35 in total

1.  Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors.

Authors:  J A Pitcher; J Inglese; J B Higgins; J L Arriza; P J Casey; C Kim; J L Benovic; M M Kwatra; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

Review 2.  G protein-coupled receptor kinases.

Authors:  J A Pitcher; N J Freedman; R J Lefkowitz
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

3.  Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr³⁴⁷, Ser³⁵⁰, and Ser³⁵⁷ in the C-terminal tail.

Authors:  Rebecca N Burns; Monalisa Singh; Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2014-01-08       Impact factor: 5.858

4.  The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation.

Authors:  Thomas F Pack; Margo I Orlen; Caroline Ray; Sean M Peterson; Marc G Caron
Journal:  J Biol Chem       Date:  2018-02-27       Impact factor: 5.157

Review 5.  Dietary Fatty Acids and Their Potential for Controlling Metabolic Diseases Through Activation of FFA4/GPR120.

Authors:  Trond Ulven; Elisabeth Christiansen
Journal:  Annu Rev Nutr       Date:  2015       Impact factor: 11.848

6.  Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein-Coupled Receptor 120.

Authors:  Rudi Prihandoko; Elisa Alvarez-Curto; Brian D Hudson; Adrian J Butcher; Trond Ulven; Ashley M Miller; Andrew B Tobin; Graeme Milligan
Journal:  Mol Pharmacol       Date:  2016-02-12       Impact factor: 4.436

Review 7.  Cyclic AMP a key messenger in the regulation of skin pigmentation.

Authors:  R Buscà; R Ballotti
Journal:  Pigment Cell Res       Date:  2000-04

8.  Genetic variants of the unsaturated fatty acid receptor GPR120 relating to obesity in dogs.

Authors:  Masahiro Miyabe; Azusa Gin; Eri Onozawa; Mana Daimon; Hana Yamada; Hitomi Oda; Akihiro Mori; Yutaka Momota; Daigo Azakami; Ichiro Yamamoto; Mariko Mochizuki; Toshinori Sako; Katsutoshi Tamura; Katsumi Ishioka
Journal:  J Vet Med Sci       Date:  2015-05-10       Impact factor: 1.267

9.  Frequency modulation of ERK activation dynamics rewires cell fate.

Authors:  Hyunryul Ryu; Minhwan Chung; Maciej Dobrzyński; Dirk Fey; Yannick Blum; Sung Sik Lee; Matthias Peter; Boris N Kholodenko; Noo Li Jeon; Olivier Pertz
Journal:  Mol Syst Biol       Date:  2015-11-27       Impact factor: 11.429

10.  Concomitant action of structural elements and receptor phosphorylation determines arrestin-3 interaction with the free fatty acid receptor FFA4.

Authors:  Adrian J Butcher; Brian D Hudson; Bharat Shimpukade; Elisa Alvarez-Curto; Rudi Prihandoko; Trond Ulven; Graeme Milligan; Andrew B Tobin
Journal:  J Biol Chem       Date:  2014-05-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.